Connecticut, Hawaii, Maryland, Oklahoma and Pennsylvania pass laws that allow pharmacists to initiate and modify drug treatments To the delight of pharmacists, collaborative practices have recently been adopted in an avalanche of states. Laws allowing pharmacists to initiate or modify drug therapy as part of the protocol with physicians have been enacted in Connecticut, Hawaii, Maryland, Oklahoma and Pennsylvania. Jillene Lewis. Five states pass community practice laws. “In the management of drug therapy, it`s not about who you work for, it`s about where the patient is,” says Robert Patti, Pharm.D., JD, clinical coordinator at York Hospital in York, Pa., and legislative president of the Pennsylvania Society of Health-System Pharmacists. Patti said he expected most pharmacists to wait for the National Pharmacy Council to develop regulations before implementing administration or vaccination protocols. This can take up to 18 months. “The board could add more to what is needed, or add finer details,” he said. Collaborative Care: Practice agreements between pharmacists and physicians allow pharmacists to administer drugs for frequent primary supply conditions. Clinical pharmacists effectively detect and resolve medication problems and keep physicians informed of care. This distinguishes our KMG service from non-clinical pharmacy services.
“We will certainly ask for this meeting again to extend it to long-term and community care practices,” said Margherita Giuliano, R.Ph., Executive Director of the Connecticut Pharmacists Association. Pharmacists already have the help of the medical society to establish cdTM in long-term care centres and they want to conduct pilot studies in municipal environments. Giuliano plans to recruit pharmacists working in disease management. “Collaborative practice is the next step in disease management.” Highly Qualified Pharmacists: Our Faculty of Ambulatory Nursing has obtained a Ph.D. in Pharmacy, completed clinical residency training and obtained certification as a pharmacotherapy specialist or outpatient pharmacist. Many are also certified diabetic educators. Connecticut has a similar strategy. By limiting CDTM to inpatients, pharmacists were able to make the bill in this state more tasty for physicians and legislators. The Connecticut CDTM also includes protocol-based practices. He pointed out, however, that many hospitals R.Ph.
are already involved in CDTM, which, under the new law, contains drug therapy protocols approved by the P-T commissions. “We have already done so,” he said. “The law is a confirmation of a practice that already existed across the country.” He believes that the law will have the greatest impact in hospitals that do not yet have such protocols. Under the new law, pharmacists could enter into agreements with physicians to manage a number of drug therapy, from starting patients to measuring blood glucose and test strips to more complex tasks such as controlling laboratory tests and adapting doses (only by protocol). Oklahoma pharmacists were able to obtain CDTM authorization, but they did so without using the term. It all started with a legal problem when the state attorney general warned that if the definition of “management” was not included in the state statutes, pharmacists would not be able to advise patients on the use of inhalers, the use of patches, insulin injection, etc.